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The androgen-secreting Leydig cells produce cGMP, but
the pathways responsible for generation, degradation,
and actions of this intracellular messenger have been
incompletely characterized in these cells. Here, we show
the presence of mRNA transcripts for several elements of
cGMP signaling pathways in purified rat Leydig cells from
adult animals, including the membrane-bound and solu-
ble guanylyl cyclases, endothelial and inducible nitric
oxide synthases, the cGMP-specific phosphodiesterase 5,
the protein kinase G (PKG), the multidrug resistance pro-
tein 5, and the rode, cone, and olfactory cyclic nucleotide-
gated channels. Increase in cGMP levels induced by stim-
ulation of membrane-bound and soluble guanylyl cyclase
activities and inhibition of phosphodiesterase 5 activity as
well as the addition of a cell permeable cGMP analog
increased basal and agonist-stimulated androgen produc-
tion in vitro. Moreover, inhibition of soluble guanylyl
cyclase and PKG activities was accompanied with attenu-
ated androgen production. Immunoprecipitation study
showed phosphorylation of the steroidogenic acute regu-
latory protein upon the treatment with nitric oxide
donors, which was abolished by the addition of a PKG
inhibitor. These results suggest that cGMP contributes to
the control of androgen production in Leydig cells
through PKG-dependent phosphorylation of steroidog-
enic acute regulatory protein.
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